Publications by authors named "David Copolov"

Claim this Profile
T
Transforming mental health facilities: Current trends and considerations.
Vlasios Brakoulias, Vinay Lakra, David Copolov

Aust N Z J Psychiatry· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seven decades of antipsychotic drugs: Why is the life of Australians with schizophrenia still so suboptimal?
David Castle, David Copolov, Bruce Singh, Tarun Bastiampillai

Aust N Z J Psychiatry· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What clinicians need to know about intranasal esketamine for treatment-resistant depression?
Judy Hope, David Copolov, John Tiller, Megan Galbally, Malcolm Hopwood

Australas Psychiatry· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between long-term use of prolactin-elevating antipsychotics in women and the risk of breast cancer: What are the clinical implications?
Judith D Hope, Nicholas A Keks, David L Copolov

Australas Psychiatry· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Myles et al.: Changing the policy narrative on psychiatric inpatient care.
Stephen Allison, Tarun Bastiampillai, Jeffrey Cl Looi, David Copolov

Aust N Z J Psychiatry· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world performance of Victorian hospitals during the COVID-19 lockdowns.
Stephen Allison, Tarun Bastiampillai, Jeffrey Cl Looi, David Copolov, Vinay Lakra

Australas Psychiatry· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Butterfly Effect: Poor access to non-acute psychiatric beds and the emergency department congestion crisis in WA.
Stephen Allison, Tarun Bastiampillai, Jeffrey Cl Looi, David Copolov

Aust N Z J Psychiatry· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re-balancing Victorian psychiatric services: Will increasing the supply of community services impact upon hospital demand?
Stephen Allison, Tarun Bastiampillai, Jeffrey Cl Looi, Sven Delaney, David Copolov

Aust N Z J Psychiatry· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antipsychotic treatment in clinical high risk for psychosis: Iatrogenesis related to dopamine supersensitivity psychosis?
Tarun Bastiampillai, Sherry Kit Wa Chan, Stephen Allison, David Copolov, Jeffrey Cl Looi

Aust N Z J Psychiatry· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Binding of SEP-363856 within TAAR1 and the 5HT receptor: implications for the design of novel antipsychotic drugs.
Pramod C Nair, John O Miners, Ross A McKinnon, Christopher J Langmead, Karen J Gregory, David Copolov

Mol Psychiatry· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Responses to the opinion-based algorithms driving the National Mental Health Service Planning Framework.
Stephen Allison, Tarun Bastiampillai, Jeffrey Cl Looi, David Copolov

Aust N Z J Psychiatry· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Australia's National Mental Health Service Planning Framework: Are opinion-based algorithms driving mental health policy?
Stephen Allison, Tarun Bastiampillai, Jeffrey Cl Looi, David Copolov

Aust N Z J Psychiatry· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Jumping off the bandwagon: Does the Basaglian de-hospitalised model work outside Trieste?
Stephen Allison, Tarun Bastiampillai, Jeffrey Cl Looi, David Copolov, Giuseppe Guaiana

Aust N Z J Psychiatry· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Tolerability of Dopamine D2/3 Receptor Partial Agonists for Schizophrenia.
Nicholas Keks, Judith Hope, Darren Schwartz, Harold McLennan, David Copolov

CNS Drugs· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to 'Have we overlooked the significance of multinodal hallucinations in schizophrenia?' [Psychiatry Research 279 (2019) 358-360].
Wei Lin Toh, Simon McCarthy-Jones, David Copolov, Susan L Rossell

Psychiatry Res· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pareto's law of the vital few: Patient requirements for hospital based non-acute care.
Stephen Allison, Tarun Bastiampillai, Jeffrey Cl Looi, David Copolov

Aust N Z J Psychiatry· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The challenges facing the public mental health sector: implications of the Victorian Psychiatry workforce project.
Richard Newton, Adele Beasley, Peter Bosanac, David Castle, David Copolov

Australas Psychiatry· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychiatric bed numbers in Australia.
Stephen Allison, Tarun Bastiampillai, David Copolov, David Castle

Lancet Psychiatry· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Have we overlooked the significance of multinodal hallucinations in schizophrenia?
Wei Lin Toh, Simon McCarthy-Jones, David Copolov, Susan L Rossell

Psychiatry Res· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Milnacipran: serotonin-noradrenaline reuptake inhibitor approved for fibromyalgia may be a useful antidepressant.
Nicholas A Keks, Judy Hope, Simone Keogh, David L Copolov

Australas Psychiatry· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Zero: Implications for public psychiatric services.
J Richard Newton, Peter Bosanac, David Copolov, Malcolm Hopwood, Nick Keks

Aust N Z J Psychiatry· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acceptance and commitment therapy for psychosis: randomised controlled trial.
Frances Shawyer, John Farhall, Neil Thomas, Steven C Hayes, Robert Gallop, David Copolov

Br J Psychiatry· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the pathophysiology of schizophrenia: Contributions from the Melbourne Psychiatric Brain Bank.
Brian Dean, David Copolov, Elizabeth Scarr

Schizophr Res· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefits of adjunctive N-acetylcysteine in a sub-group of clozapine-treated individuals diagnosed with schizophrenia.
Olivia M Dean, Serafino G Mancuso, Ashley I Bush, David Copolov, Kim Q Do

Psychiatry Res· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised controlled trial of acceptance and commitment therapy (ACT) for psychosis: study protocol.
Neil Thomas, Frances Shawyer, David J Castle, David Copolov, Steven C Hayes

BMC Psychiatry· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis